Impact of Metformin, Statin, Aspirin and Insulin on the Prognosis of Uhcc Patients Receiving First Line Lenvatinib or Atezolizumab plus Bevacizumab

AuthID
P-016-Y3A
39
Author(s)
Rimini, M
·
Montes, M
·
Amadeo, E
·
Vitiello, F
·
Kudo, M
·
Suda, G
·
[+2]·
[+4]·
[+4]·
[+2]·
[+3]·
[+4]·
Corradi, M
·
Celsa, C
·
Fabio, C
·
Frassineti, GL
·
Casadei-Gardini, A
·
Presa, J
Document Type
Article
Year published
2024
Published
in SCIENTIFIC REPORTS, ISSN: 2045-2322
Volume: 14, Issue: 1
Indexing
Publication Identifiers
Pubmed: 39215078
Scopus: 2-s2.0-85202783516
Wos: WOS:001304147400053
Source Identifiers
ISSN: 2045-2322
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Rimini, M;   2 Montes, M;   3 Amadeo, E;
4 Vitiello, F;   5 Kudo, M;   6 Tada, T;
7 Suda, G;   8 Shimose, S;   9 Lonardi, S;
10 Finkelmeier, F;   11 Salani, F;   12 Antonuzzo, L;
13 Marra, F;   14 Iavarone, M;   15 Cabibbo, G;
16 Foschi, FG;   17 Silletta, M;   18 Sacco, R;
19 Rapposelli, IG;   20 Scartozzi, M;   21 Nicoletta, P;
22 Aldrighetti, L;   23 Persano, M;   24 Camera, S;
25 Rossari, F;   26 Foti, S;   27 Kumada, T;
28 Hiraoka, A;   29 Iwamoto, H;   30 Rizzato, MD;
31 Himmelsbach, V;   32 Masi, G;   33 Corradi, M;
34 Celsa, C;   35 Fabio, C;   36 Frassineti, GL;
37 Cascinu, S;   38 Casadei-Gardini, A;   39 Presa, J;